(19)
(11) EP 4 042 873 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
27.11.2024 Bulletin 2024/48

(45) Mention of the grant of the patent:
16.10.2024 Bulletin 2024/42

(21) Application number: 22150616.5

(22) Date of filing: 19.02.2016
(51) International Patent Classification (IPC): 
A23L 2/60(2006.01)
(52) Cooperative Patent Classification (CPC):
A23L 2/60; A23L 33/125; A23L 29/30; Y02A 50/30

(54)

ALLULOSE SYRUPS

ALLULOSESIRUP

SIROPS D'ALLULOSE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 24.02.2015 US 201562120165 P
29.05.2015 US 201562168337 P

(43) Date of publication of application:
17.08.2022 Bulletin 2022/33

(60) Divisional application:
24206540.7

(62) Application number of the earlier application in accordance with Art. 76 EPC:
16708198.3 / 3261455

(73) Proprietors:
  • Tate & Lyle Solutions USA LLC
    Hoffman Estates, IL 60192 (US)
  • Tate & Lyle Technology Limited
    London W1H 7EJ (GB)

(72) Inventors:
  • WOODYER, Ryan D.
    Hoffman Estates, 60192 (US)
  • LLOYD-JONES, Peter
    Hoffman Estates, 60192 (US)

(74) Representative: Marks & Clerk LLP 
15 Fetter Lane
London EC4A 1BW
London EC4A 1BW (GB)


(56) References cited: : 
US-A1- 2012 076 908
US-A1- 2014 271 747
 US-A1- 2014 271 746
US-A1- 2014 271 748
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).